PNIE Human Anatomy 7th Edition
Celebrated for its atlas-style format, appropriately detailed anatomical illustrations, and exceptionally clear photographs of tissues and cadavers, the Seventh Edition of the award-winning Human Anatomy presents practical applications of anatomy and physiology in a highly visual format. Select Clinical Notes feature dynamic layouts that integrate text with visuals for easy reading. Clinical Cases relate clinical stories that integrate text with patient photos and diagnostic images for applied learning. Time-saving study tools, including end-of-chapter practice and review, help students arrive at a complete understanding of human anatomy. This package contains: *Human Anatomy, Seventh Edition
Out of stock
This book is for readers with some background in science, concerning the search for drugs, starting from molecular diversity in nature or molecular wilderness. Drug molecules may be used as such, or as starting points for improved drugs obtained from the interface of chemistry and biology. In some cases, the essential molecular features for drug properties from natural molecules may be identified and modified to more effective ones. In other cases, nature provides the targets, such as essential enzymes from infectious microorganisms, from which synthetic drugs can be designed. The mechanisms of action of drugs can be discerned by studying target-drug interactions. Nature may fight back, as in cases when microorganisms become resistant to drugs, but we can again use the chemistry-biology interface to obtain drugs which overcome the resistance. The battle goes on, hopefully with victory for both humans and balance of nature. This book differs from those available on the subject of natural products and drugs derived therefrom in that it looks at the broad picture on how materials and organisms from nature affect our health and how we have combined our knowledge in chemistry, biology, and biodiversity to promote our wellness from resources in the “molecular wilderness,” with caveats on sustainable utilization of these resources. It is therefore suitable, not only for readers interested in science and medicine, but also for those with interest in policy issues concerning sustainable development, environment, and issues concerning interaction of science and society in general.
About the Author
Prof. Yongyuth Yuthavong is senior research fellow at the National Science and Technology Development Agency (NSTDA) of Thailand. While working at Mahidol University, Thailand, he was given the “Outstanding Scientist of Thailand” Award (1984) for his research on malaria biochemistry. In 2004, he received the Nikkei Asia Prize for Science, Technology and Innovation from Nihon Keizai Shimbun, Inc., Japan, for his work on antimalarial drug targets. He is a former Minister of Science and Technology of Thailand (2006-2008) and was the first president of NSTDA (1992-1998). He is now involved in the development of drugs against drug-resistant malaria as well as policy issues for science and technology, and education in general. He has special interest in introducing science and technology to young people.
This significantly expanded and newest edition of the bestselling HIMSS Dictionary of Health Information Technology Terms, Acronyms, and Organizations has been developed and extensively reviewed by more than 50 industry experts. The fourth edition of this dictionary serves as a quick reference for students, health information technology professionals and healthcare executives to better navigate the ever-growing health IT field. This valuable resource includes more than 3000 definitions, 30 new organizations and 76 new references. Definitions of terms for the information technology and clinical, medical and nursing informatics fields are updated and included. This fourth edition also includes an acronyms list with cross references to current definitions, new word-search capability (e-book version only), and a list of health IT-related associations and organizations, including contact information, mission statements and web addresses. Academic and certification credentials are also included. HIMSS North America, a business unit within HIMSS, positively transforms health and healthcare through the best use of information technology in the United States and Canada. As a cause-based non-profit, HIMSS North America provides thought leadership, community building, professional development, public policy, and events. HIMSS North America represents 64,000 individual members, 640 corporate members, and over 450 non-profit organizations. Thousands of volunteers work with HIMSS to improve the quality, cost-effectiveness, access, and value of healthcare through IT. HIMSS Vision Better health through information technology. HIMSS Mission Globally, lead endeavors optimizing health engagements and care outcomes through information technology.
About the Author
HIMSS is a global voice, advisor and thought leader of health transformation through Health IT with a unique breadth and depth of expertise and capabilities to improve the quality, safety, and efficiency of health, healthcare and care outcomes. As the leading source of Health IT, HIMSS designs and leverages key data assets, predictive models and tools to advise global leaders, stakeholders and influencers of best practices in Health IT so they have the right information at the point of decision. Through its HIT network of over 1 million experts, over 200 knowledge exchanges and collaborations, including 60,000 plus members, HIMSS drives innovative; forward thinking around best uses of technology in support of better connected care, improved population health and low cost of care. HIMSS is a not for profit, headquartered in Chicago, Illinois with additional offices in North America, Latin America, Europe, United Kingdom and Asia.
Since scientists began experimenting with green fluorescent proteins in the middle of the 1990s, these proteins have become one of the most important tools available to researchers in modern medicine and biology. By using them to illuminate other proteins that were previously invisible even under microscope, scientists are now able to observe facets of disease that would have otherwise gone undetected. Green fluorescent proteins are a part of over three million experiments a year, and are invaluable for tasks such as tracking HIV, breeding bird flu-resistant chickens, and confirming the existence of cancerous stem cells. In Illuminating Disease, Marc Zimmer introduces us to these revolutionary proteins, acquainting readers both with the researchers responsible for the proteins’ discovery as well as their wide utility. The book details the history of genetically modified fluorescent parasites and viruses, which provide scientists with new information about the spread of diseases. Green fluorescent proteins have played crucial roles in the research of malaria, AIDS/HIV, swine and bird flu, dengue, cancer, and chagas. They allow scientists and doctors to understand these diseases better, by quite literally illuminating various microscopic pieces that otherwise would have gone unseen. The book is richly illustrated, showing the many visually striking uses of GFP. Many of these scans have won awards in biological imaging competitions. Illuminating Disease is an accessible and illustrated introduction to one of the most important developments in medical research of the last several decades.
About the Author
Marc Zimmer is Professor of Chemistry at Connecticut College. He has published articles on science and medicine for the Los Angeles Times and the Huffington Post, among many other publications.
Evidence-Based Validation of Herbal Medicines brings together current thinking and practice in the areas of characterization and validation of natural products. This book reviews all aspects of evaluation and development of medicines from plant sources, including their cultivation, collection, phytochemical and phyto-pharmacological evaluation, and therapeutic potential. Emphasis is placed on describing the full range of evidence-based analytical and bio-analytical techniques used to characterize natural products, including -omic technologies, phyto-chemical analysis, hyphenated techniques, and many more. * Includes state-of-the-art methods for detecting, isolating, and performing structure elucidation by degradation and spectroscopic techniques* Covers biosynthesis, synthesis, and biological activity related to natural products* Consolidates information to save time and money in research* Increases confidence levels in quality and validity of natural products.
About the Author
Dr. Pulok K. Mukherjee, Director, School of Natural Product Studies, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India, has been working on traditional medicine inspired drug discovery leading to development of therapeutic leads from natural resources. His research work highlights screening, evaluation, formulation, and standardization of herbal drugs with their validation to ensure quality, safety, and efficacy. He has made innovative, outstanding, and original contributions both in education and research in the area of natural products. Dr. Mukherjee is a Fellow of the Royal Society of Chemistry (FRSC), UK. He completed his masters and PhD in pharmacy from Jadavpur University and post-doctoral research from Leiden/Amsterdam Center for Drug Research, The Netherlands. His research career has been outstanding, including globally-acclaimed contributions on evaluation of the holistic medicine as useful bio-prospecting tools for the traditional medicine based drug discovery program so as to make them available from “Farm to Pharma . His work has led to many important national and international projects in the field of Natural Health Products. He has worked on leveraging innovations in traditional Indian medicine, particularly on rationally designed, carefully standardized, synergistic traditional herbal formulations and botanical drugs for their scientific validation on evidence based approaches. His efforts on development of integrated approaches for drug development from Indian traditional medicine have worldwide impact for the promotion of traditional medicine inspired drug discovery. Based on these works, he has to his credit more than 174 publications in peer reviewed impact journals, several patents and 20 books/book chapters on various aspects of herbal medicine. His research publications have a cumulative Impact Factor of 186.43. Google Citations database indicates that his works have h-Index- 41, i10-index- 126; which has been cited over 7630 times. He has worked as visiting scientist in several renowned universities abroad including The School of Pharmacy, University of London; King’s College London; Leiden/Amsterdam Center for Drug Research, Netherlands; School of Health Science, Tokushima University, Japan; Medical Research Council, Cape Town, South Africa. He has developed several products, and processes with partnership between industry and institutes. He has been awarded with many laurels from the Government of India and abroad; to name a few: the prestigious Commonwealth Academic Staff Fellowship from the Association of Commonwealth Universities (ACU), UK; Outstanding Service Award from the Drug Information Association (DIA), USA; Career Award for Young Teachers from the All India Council for Technical Education (AICTE), Government of India; Overseas Award from the Department of Biotechnology (DBT), BOYSCAST Fellowship from Department of Science & Technology (DST), Government of India; Young Pharmacy Teacher Award from the Association of Pharmaceutical Teachers of India; and the IPA Fellowship Award from the Indian Pharmaceutical Association (IPA). Dr. Mukherjee is working on the dissemination of knowledge on promotion and development of natural products with international coordination and collaboration on globalizing local knowledge and localizing global technologies in the area of traditional medicine. He has delivered over 200 lectures at different international and national podiums on leveraging innovations in traditional Indian medicine particularly on its validation for the safety, quality, and efficacy with the evidence based scientific claims. He has organized 16 potential national and international conferences, workshops, and seminars with the involvement of scientists all over the world. He is actively involved with several professional organizations. He is Member of the board on International Society for Ethnopharmacology, UK; Secretary of the Society for Ethnopharmacology (SFE), India; Council member of the Society for TCM Pharmaceutical Analysis, China; and others. Dr. Mukherjee is serving as Associate Editor of the Journal of Ethnopharmacology, Elsevier Science. He is the member of the editorial board of ten other Indian and international journals. He is also associated as advisor to different organizations and administrative bodies of the Government of India and abroad.